Arkolith/Insider Trading/RPHM/Form 4

Muralidhar Bali

DirectorReneo Pharmaceuticals, Inc. (RPHM) · full profile →Form 4 · filed May 28, 2021
Net Buying
Open-Market Buys
$66K
Open-Market Sells
$0
Net Open-Market Flow
$66K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 27, 2021Buy(P)1K$9.26$10K1.9M
May 26, 2021Buy(P)6K$9.38$55K1.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905718-21-000738) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML